The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Open accessAbstract
The elucidation of breast cancer subgroups and their molecular drivers requires integrated views of the genome and transcriptome from representative numbers of patients. We present an integrated analysis of copy number and gene expression in a discovery and validation set of 997 and 995 primary breast tumours, respectively, with long-term clinical follow-up. Inherited variants (copy number variants and single nucleotide polymorphisms) and acquired somatic copy number aberrations (CNAs) were associated with expression in ~40% of genes, with the landscape dominated by cis- and trans-acting CNAs. By delineating expression outlier genes driven in cis by CNAs, we identified putative cancer genes, including deletions in PPP2R2A, MTAP and MAP2K4. Unsupervised analysis of paired DNA–RNA profiles revealed novel subgroups with distinct clinical outcomes, which reproduced in the validation cohort. These include a high-risk, oestrogen-receptor-positive 11q13/14 cis-acting subgroup and a favourable prognosis subgroup devoid of CNAs. Trans-acting aberration hotspots were found to modulate subgroup-specific gene networks, including a TCR deletion-mediated adaptive immune response in the ‘CNA-devoid’ subgroup and a basal-specific chromosome 5 deletion-associated mitotic network. Our results provide a novel molecular stratification of the breast cancer population, derived from the impact of somatic CNAs on the transcriptome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Currently, numerous research efforts are focused on utilizing genetic data and artificial intelligence algorithms to develop diagnostic models to enhance the clinical efficiency and accuracy of breast cancer diagnosis [109,110,111].”
From A Comprehensive Review on Synergy of Multi-Modal Data and AI Technologies in Medical Diagnosis (2024) · cites this paper as [111]
In the citing paper
“This framework was also employed for a landmark study which used genomic and transcriptomic data from 2,000 breast tumours and discovered novel subgroups amongst them (Curtis et al., 2012).”
From Using machine learning approaches for multi-omics data analysis: A review (2021) · cites this paper as Curtis et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551
Self-citationNishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
Self-citationSupervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S. C. Y., Voduc, D. K., Vickery, T. L., Davies, S. R., Fauron, C. M. ‐., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,818
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Ki67 expression in breast cancer
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Diagnosis of multiple cancer types by shrunken centroids of gene expression
Tibshirani, R. J., Hastie, T. J., Narasimhan, B., & Chu, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082099299 · Cited by 2,931
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,411
Self-citationGenomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A. V., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,309
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T., Shih, I., Mao, T., Nakayama, K., Roden, R. B. S., Glas, R., Slamon, D. J., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,218
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,028
CancerDR: Cancer Drug Resistance Database
Kumar, R., Chaudhary, K., Gupta, S., Singh, H., Kumar, S., Gautam, A., Kapoor, P., & Raghava, G. P. S. (2013) · Scientific Reports · doi:10.1038/srep01445 · Cited by 129
Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity
Wolf, D. M., Lenburg, M. E., Yau, C. S. F., Boudreau, A., & Veer, L. V. ‘. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088309 · Cited by 128
miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway
Samaeekia, R., Adorno-Cruz, V., Bockhorn, J., Chang, Y.-F., Huang, S., Prat, A., Ha, N., Kibria, G., Huo, D., Zheng, H., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0943 · Cited by 128
Wang, C., Lai, M.-D., Phan, N. N., Sun, Z., & Lin, Y.-C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125766 · Cited by 135
Next generation sequencing in cancer research and clinical application
Shyr, D., & Liu, Q. (2013) · Biological Procedures Online · doi:10.1186/1480-9222-15-4 · Cited by 130
Multi-modal advanced deep learning architectures for breast cancer survival prediction
Arya, N., & Saha, S. (2021) · Knowledge-Based Systems · doi:10.1016/j.knosys.2021.106965 · Cited by 127
Asleh, K., Negri, G. L., Miko, S. E. S., Colborne, S., Hughes, C. S., Wang, X. Q., Gao, D., Gilks, C. B., Chia, S., Nielsen, T. O., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28524-0 · Cited by 132
Kalev, P., Šimíček, M., Vázquez, I., Munck, S., Chen, L., Soin, T., Danda, N., Chen, W. L., & Sablina, A. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1667 · Cited by 128
Inhibitors of p21-Activated Kinases (PAKs)
Rudolph, J., Crawford, J. J., Hoeflich, K. P., & Wang, W. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501613q · Cited by 128
Yuan, Y. (2014) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.1153 · Cited by 128
Self-citationMarusyk, A., Tabassum, D. P., Janiszewska, M., Place, A. E., Trinh, A. C., Rozhok, A. I., Pyne, S., Guerriero, J. L., Shu, S., Ekram, M. B., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1457 · Cited by 129
Immune Infiltration in Invasive Lobular Breast Cancer
Desmedt, C., Salgado, R., Fornili, M., Pruneri, G., den Eynden, G. V., Zoppoli, G. M., Rothé, F., Buisseret, L., Garaud, S., Willard-Gallo, K. E., et al. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx268 · Cited by 126
Self-citationA patient‐derived explant ( PDE ) model of hormone‐dependent cancer
Centenera, M. M., Hickey, T. E., Jindal, S., Ryan, N. K., Ravindranathan, P., Mohammed, H., Robinson, J. L. L., Schiewer, M. J., Ma, S., Kapur, P., et al. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12354 · Cited by 126
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Moreno, E., Cavic, M. R., Krivokuća, A., Casadó, V., & Canela, E. I. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00339 · Cited by 129
PRMT inhibition induces a viral mimicry response in triple-negative breast cancer
Wu, Q., Nie, D. Y., Ba-Alawi, W., Ji, Y., Zhang, Z., Cruickshank, J., Haight, J., Ciamponi, F. E., Chen, J., Duan, S., et al. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01024-4 · Cited by 132
Metastatic breast cancer subtypes and central nervous system metastases
Aversa, C., Rossi, V., Geuna, E., Martinello, R., Milani, A., Redana, S., Valabrega, G., Aglietta, M., & Montemurro, F. (2014) · The Breast · doi:10.1016/j.breast.2014.06.009 · Cited by 126
Uterine adenosarcomas are mesenchymal neoplasms
Piscuoglio, S., Burke, K. A., Ng, C. K. Y., Papanastasiou, A. D., Geyer, F. C., Macedo, G. S., Martelotto, L. G., de Bruijn, I., Filippo, M. R. D., Schultheis, A. M., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4675 · Cited by 125
Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes
Messier, T., Gordon, J. A. R., Boyd, J. R., Tye, C. E., Browne, G., Stein, J. L., Lian, J. B., & Stein, G. S. (2016) · Oncotarget · doi:10.18632/oncotarget.6922 · Cited by 132
Moving towards a molecular taxonomy of autoimmune rheumatic diseases
Barturen, G., Beretta, L., Cervera, R., van Vollenhoven, R., & Alarcón-Riquelme, M. E. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.220 · Cited by 127
Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice
Rogers, Z. N., McFarland, C. D., Winters, I. P., Seoane, J. A., Brady Jennifer, J., Yoon, S. M., Curtis, C. N., Petrov, D. A., & Winslow, M. M. (2018) · Nature Genetics · doi:10.1038/s41588-018-0083-2 · Cited by 125
Self-citationTan, R. S. Y. C., Ong, W. S., Lee, K.-H., Lim, A. H., Park, S., Park, Y. H., Lin, C., Lu, Y., Ono, M., Ueno, T., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02284-6 · Cited by 125
Zubair, H., Khan, H. Y., Sohail, A., Azim, S., Ullah, M. F., Ahmad, A., Sarkar, F. H., & Hadi, S. M. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.172 · Cited by 126
Dushyanthen, S., Teo, Z. L., Caramia, F., Savas, P., Mintoff, C. P., Virassamy, B., Henderson, M. A., Luen, S. J., Mansour, M., Kershaw, M. H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00728-9 · Cited by 124
The cancer biology of whole-chromosome instability
Duijf, P. H. G., & Benezra, R. (2013) · Oncogene · doi:10.1038/onc.2012.616 · Cited by 125
Multi-omics strategies for biomarker discovery and application in personalized oncology
Jiang, Z., Zhang, H., Gao, Y., & Sun, Y. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00340-0 · Cited by 143
Metastatic breast carcinomas display genomic and transcriptomic heterogeneity
Weigelt, B., Ng, C. K. Y., Shen, R., Popova, T. G., Schizas, M., Natrajan, R., Mariani, O., Stern, M., Norton, L., Vincent‐Salomon, A., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.142 · Cited by 123
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples
Martelotto, L. G., Baslan, T., Kendall, J., Geyer, F. C., Burke, K. A., Spraggon, L., Piscuoglio, S., Chadalavada, K., Nanjangud, G. J., Ng, C. K. Y., et al. (2017) · Nature Medicine · doi:10.1038/nm.4279 · Cited by 126
ERα-associated translocations underlie oncogene amplifications in breast cancer
Lee, J. J.-K., Jung, Y. L., Cheong, T.-C., Valle-Inclán, J. E., Chu, C., Gulhan, D., Ljungström, V., Jin, H., Viswanadham, V., Watson, E. V., et al. (2023) · Nature · doi:10.1038/s41586-023-06057-w · Cited by 125
Phosphatidylinositol‐4‐phosphate: The Golgi and beyond
Matteis, M. A. D., Wilson, C., & D’Angelo, G. (2013) · BioEssays · doi:10.1002/bies.201200180 · Cited by 122
Margolin, A. A., Bilal, E., Huang, E. S., Norman, T., Ottestad, L., Mecham, B. H., Sauerwine, B., Kellen, M., Mangravite, L. M., Furia, M. D., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006112 · Cited by 123
Self-citationBreast cancer subtypes: response to radiotherapy and potential radiosensitisation
Langlands, F. E., Horgan, K. J., Dodwell, D., & Smith, L. (2013) · British Journal of Radiology · doi:10.1259/bjr.20120601 · Cited by 122
Cell‐free circulating tumour DNA as a liquid biopsy in breast cancer
Mattos‐Arruda, L. D., & Caldas, C. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.001 · Cited by 124
Self-citationShort-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells
Thirunavukkarasan, M., Wang, C., Rao, A., Hind, T., Teo, Y. L., Siddiquee, A. A.-M., Goghari, M. A. I., Kumar, A. P., & Herr, D. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186334 · Cited by 124
Mele, L. L., Noce, M. L., Paino, F., Regad, T., Wagner, S., Liccardo, D., Papaccio, G., Lombardi, A., Caraglia, M., Tirino, V., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1164-5 · Cited by 122
Stahlberg, E. A., Abdel‐Rahman, M. H., Aguilar, B. H., Asadpoure, A., Beckman, R. A., Borkon, L. L., Bryan, J. N., Cebulla, C. M., Chang, Y. H., Chatterjee, S., et al. (2022) · Frontiers in Digital Health · doi:10.3389/fdgth.2022.1007784 · Cited by 122
Optimizing sparse sequencing of single cells for highly multiplex copy number profilingPreprint
Baslan, T., Kendall, J., Ward, B., Cox, H., Leotta, A., Rodgers, L., Riggs, M. G., D'Italia, S., Sun, G., Mao, Y., et al. (2015) · Genome Research · doi:10.1101/gr.188060.114 · Cited by 123
An approach for normalization and quality control for NanoString RNA expression data
Bhattacharya, A., Hamilton, A. M., Furberg, H., Pietzak, E., Purdue, M. P., Troester, M. A., Hoadley, K. A., & Love, M. I. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa163 · Cited by 122
Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
Pérez-Gómez, E., Andradas, C., Blasco-Benito, S., Caffarel, M. M., García-Taboada, E., Villa‐Morales, M., Moreno, E., Hamann, S., Martín-Villar, E., Flores, J. M., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv077 · Cited by 124
Breunig, C., Pahl, J. H. W., Kueblbeck, M., Miller, M., Antonelli, D., Erdem, N., Wirth, C., Will, R. D., Bott, A., Cerwenka, A., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.364 · Cited by 121
Montaudon, É., Nikitorowicz-Buniak, J., Sourd, L., Morisset, L., Botty, R. E., Huguet, L., Dahmani, A., Painsec, P., Némati, F., Vacher, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17697-1 · Cited by 124
Klughammer, J., Abravanel, D. L., Segerstolpe, Å., Blosser, T. R., Goltsev, Y., Cui, Y., Goodwin, D., Sinha, A., Ashenberg, O., Slyper, M., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03215-z · Cited by 122
CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer
Yoshida, T., Kim, J. H., Carver, K. C., Su, Y., Weremowicz, S., Mulvey, L. A., Yamamoto, S., Brennan, C. W., Mei, S., Long, H. W., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2443 · Cited by 120
Watkins, J. A., Weekes, D. B., Shah, V., Gazińska, P., Joshi, S. P., Sidhu, B., Gillett, C., Pinder, S. E., Vanoli, F., Jasin, M., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1092 · Cited by 120
Self-citationMardakheh, F. K., Paul, A., Kuemper, S., Sadok, A., Paterson, H., McCarthy, A., Yuan, Y., & Marshall, C. J. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.10.005 · Cited by 120
Self-citationCapture Hi-C identifies putative target genes at 33 breast cancer risk loci
Baxter, J. S., Leavy, O. C., Dryden, N. H., Maguire, S. L., Johnson, N., Fedele, V., Simigdala, N., Martin, L., Andrews, S., Wingett, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03411-9 · Cited by 123
Harnessing synthetic lethality to predict the response to cancer treatment
Lee, J. S., Das, A., Jerby‐Arnon, L., Arafeh, R., Auslander, N., Davidson, M. A., McGarry, L., James, D. T., Amzallag, A., Park, S. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04647-1 · Cited by 122
Tkach, M., Thalmensi, J., Timperi, E., Gueguen, P., Névo, N., Grisard, E., Sirven, P., Cocozza, F., Gouronnec, A., Jaular, L. M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107394119 · Cited by 121
Ward, A., Shukla, K., Balwierz, A., Soons, Z. I. T. A., König, R., Şahin, Ö., & Wiemann, S. (2014) · The Journal of Pathology · doi:10.1002/path.4363 · Cited by 119
Genomic Medicine Frontier in Human Solid Tumors: Prospects and Challenges
Dienstmann, R., Rodon, J. A., Barretina, J., & Tabernero, J. M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2268 · Cited by 120
Thrombospondin-4 in tissue remodeling
Stenina‐Adognravi, O., & Plow, E. F. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.11.006 · Cited by 120
Tu, W. B., Shiah, Y.-J., Lourenco, C., Mullen, P. J., Dingar, D. D., Redel, C., Tamachi, A., Ba-Alawi, W., Aman, A. M., Al‐awar, R., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.09.001 · Cited by 119
Hongu, T., Pein, M., Insua-Rodríguez, J., Gutjahr, E., Mattavelli, G., Meier, J., Decker, K., Descot, A., Bozza, M., Harbottle, R., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00353-6 · Cited by 118
Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer
Johnstone, C. N., Chand, A. L., Putoczki, T. L., & Ernst, M. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.015 · Cited by 122
Chia, S., Gandhi, S., Joy, A. A., Edwards, S., Gorr, M., Hopkins, S. P., Kondejewski, J., Ayoub, J.-P., Califaretti, N., Rayson, D., et al. (2015) · Current Oncology · doi:10.3747/co.22.2393 · Cited by 118
MELK is an oncogenic kinase essential for mitotic progression in basal-like breast cancer cells
Wang, Y., Lee, Y., Baitsch, L., Huang, A., Xiang, Y., Tong, H., Lako, A., Von, T., Choi, C. H., Lim, E., et al. (2014) · eLife · doi:10.7554/elife.01763 · Cited by 118
Abdel-Fatah, T. M. A., Agarwal, D., Liu, D., Russell, R., Rueda, O. M., Liu, K., Xu, B., Moseley, P. M., Green, A. R., Pockley, A. G., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)00174-1 · Cited by 118
Self-citationYang, Y.-A., Yang, H. H., Hu, Y., Watson, P. H., Liu, H., Geiger, T. R., Anver, M. R., Haines, D. C., Martin, P., Green, J. E., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15695 · Cited by 122
Self-citationFu, J., Yang, D., Jin, M., Liu, W., Zhao, X. H., Li, C., Zhao, T., Wang, J., Gao, Z., Shen, Z., et al. (2017) · Molecular Ecology · doi:10.1111/mec.14255 · Cited by 118
Pitt, J. J., Riester, M., Zheng, Y., Yoshimatsu, T. F., Sanni, A., Oluwasola, O., Veloso, A., Labrot, E., Wang, S., Odetunde, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06616-0 · Cited by 123
A Machine Learning Approach for Identifying Gene Biomarkers Guiding the Treatment of Breast Cancer
Tabl, A. A., Alkhateeb, A., ElMaraghy, W. H., Rueda, L. G., & Ngom, A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00256 · Cited by 118
FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance
de Moraes, G. N., Delbue, D., Silva, K. L., Robaina, M. C., Khongkow, P., Gomes, A., Zona, S., Crocamo, S., Mencalha, A. L., Magalhães, L. M., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.09.013 · Cited by 121
Božović‐Spasojević, I., Zardavas, D., Brohée, S., Ameye, L., Fumagalli, D., Ades, F., de Azambuja, E., Barèche, Y., Piccart, M. J., Paesmans, M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0979 · Cited by 117
Tsao, L.-C., Crosby, E. J., Trotter, T. N., Agarwal, P., Hwang, B.-J., Acharya, C. R., Shuptrine, C. W., Wang, T., Wei, J.-P., Yang, X. Y., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.131882 · Cited by 120
Arya, N., & Saha, S. (2020) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2020.3018467 · Cited by 117
Zhao, Y., Pan, Z., Namburi, S., Pattison, A., Posner, A., Balachander, S., Paisie, C. A., Reddi, H. V., Rueter, J., Gill, A. J., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103030 · Cited by 120
Molecular classification of hormone receptor-positive HER2-negative breast cancer
Jin, X., Zhou, Y.-F., Ma, D., Zhao, S., Lin, C., Xiao, Y., Fu, T., Liu, C., Chen, Y., Xiao, W.-X., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01507-7 · Cited by 118
A single-cell atlas enables mapping of homeostatic cellular shifts in the adult human breast
Reed, A. D., Pensa, S., Steif, A., Stenning, J., Kunz, D. J., Porter, L. J., Hua, K., He, P., Twigger, A., Siu, A. J. Q., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01688-9 · Cited by 131
Day, S., Coombes, R. C., McGrath‐Lone, L., Schoenborn, C., & Ward, H. (2017) · Sociology of Health & Illness · doi:10.1111/1467-9566.12457 · Cited by 117
Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells
Nguyen, L. V., Pellacani, D., Lefort, S., Kannan, N., Osako, T., Makarem, M., Cox, C. L., Kennedy, W., Beer, P. A., Carles, A., et al. (2015) · Nature · doi:10.1038/nature15742 · Cited by 116
Self-citationRORγt+ Innate Lymphoid Cells Promote Lymph Node Metastasis of Breast Cancers
Irshad, S., Flores‐Borja, F., Lawler, K., Monypenny, J., Evans, R., Male, V. H., Gordon, P., Cheung, A., Gazińska, P., Noor, F., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-0598 · Cited by 116
Self-citationExome-capture RNA sequencing of decade-old breast cancers and matched decalcified bone metastases
Priedigkeit, N., Watters, R. J., Lucas, P. C., Basudan, A., Bhargava, R., Horne, W. T., Kolls, J. K., Fang, Z., Rosenzweig, M. Q., Brufsky, A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.95703 · Cited by 116
Sjöberg, E., Meyrath, M., Milde, L., Herrera, M., Lövrot, J., Hägerstrand, D., Frings, O., Bartish, M., Rolny, C., Sonnhammer, E. L. L., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1294 · Cited by 116
Shinde, A., Hardy, S. D., Kim, D., Akhand, S. S., Jolly, M. K., Wang, W.-H., Anderson, J. C., Khodadadi, R. B., Brown, W. S., George, J. T., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2636 · Cited by 115
VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug
Kim, M., Jang, K., Miller, P., Picon‐Ruiz, M., Yeasky, T. M., El‐Ashry, D., & Slingerland, J. M. (2017) · Oncogene · doi:10.1038/onc.2017.4 · Cited by 116
O’Donnell, S. T., Ross, R. P., & Stanton, C. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03084 · Cited by 118
Manjunath, M., & Choudhary, B. (2021) · Oncology Letters · doi:10.3892/ol.2021.12773 · Cited by 123
’Personalized Medicine’: What’S in a Name?
Pokorska-Bocci, A., Stewart, A., Sagoo, G. S., Hall, A., Kroese, M., & Burton, H. (2014) · Personalized Medicine · doi:10.2217/pme.13.107 · Cited by 114
KLF6-SV1 Drives Breast Cancer Metastasis and Is Associated with Poor Survival
Hatami, R., Sieuwerts, A. M., Izadmehr, S., Yao, Z., Qiao, R., Papa, L., Look, M. P., Smid, M., Ohlseen, J., Levine, A. C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004688 · Cited by 117
Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition
Chen, X., Low, K.-H., Alexander, A., Jiang, Y., Karakaş, C., Hess, K. R., Carey, J. P. W., Bui, T. N., Vijayaraghavan, S., Evans, K. W., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1446 · Cited by 118
Self-citationThe Genomic and Immune Landscapes of Lethal Metastatic Breast Cancer
Mattos‐Arruda, L. D., Sammut, S., Ross, E. M., Bashford-Rogers, R. J. M., Greenstein, E., Markus, H., Morganella, S., Teng, Y. H. F., Maruvka, Y. E., Pereira, B., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.04.098 · Cited by 117
Self-citationLi, F., Miao, L., Xue, T., Qin, H., Mondal, S., Thompson, P. R., Coonrod, S. A., Liu, X., & Zhang, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1404-8 · Cited by 114
Hutchinson, K. E., Yost, S. E., Chang, C., Johnson, R. M., Carr, A. R., McAdam, P. R., Halligan, D. L., Chang, C.-C., Schmolze, D. B., Liang, J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1773 · Cited by 116
Self-citationMolecular analysis of TCGA breast cancer histologic types
Thennavan, A., de Beça, F. F., Xia, Y., García‐Recio, S., Allison, K. H., Collins, L. C., Tse, G. M.-K., Chen, Y., Schnitt, S. J., Hoadley, K. A., et al. (2021) · Cell Genomics · doi:10.1016/j.xgen.2021.100067 · Cited by 114
Role of Obesity in the Risk of Breast Cancer: Lessons from Anthropometry
Amadou, A., Hainaut, P. L., & Romieu, I. (2013) · Journal of Oncology · doi:10.1155/2013/906495 · Cited by 114
Predicting response and survival in chemotherapy-treated triple-negative breast cancer
Prat, A., Lluch, A. M., Albanell, J., Barry, W. T., Fan, C., Chacón, J. I., Parker, J. S., Calvo, L., Plazaola, A., Arcusa, À., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.444 · Cited by 113
Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis
Pavlović, M., Estape, A. A., Rojo, F., Bellmunt, A., Tarragona, M., Guiu, M., Planet, E., García‐Albéniz, X., Morales, M. L. G., Urosevic, J., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv256 · Cited by 113
Blocking immunosuppressive neutrophils deters pY696-EZH2–driven brain metastases
Zhang, L., Yao, J., Wei, Y., Zhou, Z., Li, P., Qu, J., Badu-Nkansah, A., Yuan, X., Huang, Y.-W., Fukumura, K., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz5387 · Cited by 113
Yang, C., Chen, H., Tan, G., Gao, W., Cheng, L., Jiang, X., Li, Y., & Tan, Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.004 · Cited by 115
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
Ghoussaini, M., Edwards, S. L., Michailidou, K., Nord, S., Sallari, R. C., Desai, K., Kar, S., Hillman, K. M., Kaufmann, S., Glubb, D. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5999 · Cited by 117
Wang, J., Tsouko, E., Jonsson, P., Bergh, J. C. S., Hartman, J., Aydoğdu, E., & Williams, C. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.07.006 · Cited by 112
Pettersen, E. O., Ebbesen, P., Gieling, R. G., Williams, K. J., Dubois, L. J., Lambin, P., Ward, C., Meehan, J., Kunkler, I. H., Langdon, S. P., et al. (2014) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2014.966704 · Cited by 116
Improving Breast Cancer Survival Analysis through Competition-Based Multidimensional Modeling
Bilal, E., Dutkowski, J., Guinney, J., Jang, I. S., Logsdon, B. A., Pandey, G. S., Sauerwine, B., Shimoni, Y., Vollan, H. K. M., Mecham, B. H., et al. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003047 · Cited by 113
Self-citationCampbell, K. R., Steif, A., Laks, E., Zahn, H., Lai, D., McPherson, A., Farahani, H., Kabeer, F., O’Flanagan, C. H., Biele, J., et al. (2019) · Genome biology · doi:10.1186/s13059-019-1645-z · Cited by 112
Self-citationBhat‐Nakshatri, P., Gao, H., Liu, S., McGuire, P. C., Xuei, X., Wan, J., Liu, Y., Althouse, S. K., Colter, A. B., Sandusky, G. E., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100219 · Cited by 115
Non-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer
Kauko, O., & Westermarck, J. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.01.005 · Cited by 111
Classical pathology and mutational load of breast cancer – integration of two worlds
Budczies, J., Bockmayr, M. L., Denkert, C., Klauschen, F., Lennerz, J. K., Győrffy, B., Dietel, M., Loibl, S., Weichert, W., & Stenzinger, A. (2015) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.25 · Cited by 114
Lee, H., Palm, J., Grimes, S. M., & Ji, H. P. (2015) · Genome Medicine · doi:10.1186/s13073-015-0226-3 · Cited by 115
Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast
Piscuoglio, S., Ng, C. K. Y., Geyer, F. C., Burke, K. A., Cowell, C. F., Martelotto, L. G., Natrajan, R., Popova, T. G., Maher, C. A., Lim, R. S., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0048-0 · Cited by 111
Dutta, P., Sarkissyan, M., Paico, K., Wu, Y., & Vadgama, J. V. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4760-8 · Cited by 115
Insua‐Rodríguez, J., Pein, M., Hongu, T., Meier, J., Descot, A., Lowy, C., Braekeleer, E. D., Sinn, H., Spaich, S., Sütterlin, M., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809003 · Cited by 115
Metadata
- Authors
- METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., Yuan, Y., Gräf, S., Ha, G., Haffari, G., Bashashati, A., Russell, R., McKinney, S., Langerød, A., Green, A., Provenzano, E., Wishart, G., Pinder, S., Watson, P., Markowetz, F., Murphy, L., Ellis, I., Purushotham, A., Børresen-Dale, A.-L., Brenton, J. D., Tavaré, S., Caldas, C., & Aparicio, S.
- Affiliations
- University of Cambridge (GB)
- University of British Columbia (CA)
- Oslo University Hospital (NO)
- University of Nottingham (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- King's College London (GB)
- University of Southern California (US)
- Corresponding author
- Caldas, Carlos
- Aparicio, Samuel
- ORCID
- Curtis, Christina
- Shah, Sohrab P.
- Chin, Suet-Feung
- Turashvili, Gulisa
- Rueda, Oscar M.
- Dunning, Mark J.
- Speed, Doug
- Lynch, Andy G.
- Samarajiwa, Shamith
- Yuan, Yinyin
- Gräf, Stefan
- Ha, Gavin
- Haffari, Gholamreza
- Bashashati, Ali
- Green, Andrew
- Provenzano, Elena
- Wishart, Gordon
- Pinder, Sarah
- Watson, Peter
- Markowetz, Florian
- Murphy, Leigh
- Ellis, Ian
- Purushotham, Arnie
- Brenton, James D.
- Tavaré, Simon
- Caldas, Carlos
- Aparicio, Samuel
- Venue
- Nature
- Published
- 2012-04-18
- Volume
- 486
- Issue
- 7403
- Pages
- 346-352
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3440846
- OpenAlex
- W2005895632
- Cited by
- 6,097
- References
- 32
- Citations by year
- 2026: 341 · 2025: 411 · 2024: 458 · 2023: 497 · 2022: 496 · 2021: 615 · 2020: 533 · 2019: 449 · 2018: 426 · 2017: 361 · 2016: 373 · 2015: 378 · 2014: 339 · 2013: 291 · 2012: 119
- FWCI
- 119.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- University of Southern California
- Michael Smith Health Research BC
- Cancer Research UK (A7199, 15601, 19556)
- National Institute for Health and Care Research (ACF-2012-14-006, NF-SI-0611-10154)
- University of Cambridge
- King's College London
- National Institutes of Health
- BC Cancer Agency
- NIHR Cambridge Biomedical Research Centre
- National Human Genome Research Institute (P50-HG02790, P50HG002790)
- Division of Mathematical Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- breast cancer, copy number alterations, somatic copy number alterations, gene expression, single nucleotide polymorphisms, PPP2R2A, MTAP, MAP2K4, estrogen receptor-positive breast cancer, adaptive immune response, basal-like breast cancer, chromosome 5 deletion, molecular stratification, prognosis
- MeSH terms
- Breast Neoplasms, Female, Humans, Prognosis, Genome, Human, Gene Expression Regulation, Neoplastic, Treatment Outcome, Polymorphism, Single Nucleotide, Gene Expression Profiling, Genomics, MAP Kinase Kinase 4, Genes, Neoplasm, Kaplan-Meier Estimate, Gene Regulatory Networks, Protein Phosphatase 2, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
